+3,937.5%
NUE vs IVZ
+930.4%
+3,007.1%
-68.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -3.1% | +1.9% | 0.0% |
| 7D | -5.1% | -1.7% | -3.4% | -4.5% |
| 30D | -5.4% | -2.8% | -2.6% | -4.5% |
| 3M | -0.3% | -13.1% | +12.8% | +4.9% |
| 6M | +12.1% | +6.4% | +5.7% | +8.0% |
| YTD | +52.9% | +8.9% | +44.0% | +44.9% |
| 1Y | +68.5% | +24.9% | +43.6% | +50.7% |
| 3Y | +64.6% | +127.0% | -62.4% | +13.2% |
| 5Y | +135.8% | +42.2% | +93.6% | +91.5% |
| 10Y | +419.7% | +37.8% | +381.9% | +290.6% |
| All | +3,937.5% | +930.4% | +3,007.1% | +1,746.1% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling